Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based

Abdel Aziz M Shaheen1, Gilaad G Kaplan, James N Hubbard

  • 1Liver Unit, Department of Medicine, Division of Gastroenterology, University of Calgary, Calgary, AB, Canada.

Insights

Patients with cirrhosis undergoing coronary artery bypass graft (CABG) surgery face significantly higher risks of mortality and complications. This population-based study highlights the increased morbidity and mortality associated with CABG in cirrhotic patients.

Area of Science:

  • Cardiovascular Surgery
  • Hepatology
  • Transplantation

Background:

  • The surgical risks for patients with cirrhosis undergoing coronary artery bypass graft (CABG) surgery are not well-established.
  • This study aimed to define the outcomes of CABG in patients with cirrhosis from a population-based perspective.

Purpose of the Study:

  • To evaluate the outcomes of coronary artery bypass graft (CABG) surgery in patients diagnosed with cirrhosis.
  • To assess the impact of cirrhosis on mortality, complications, length of stay, and healthcare charges following CABG.

Main Methods:

  • Analysis of the 1998-2004 Nationwide In-patient Sample database to identify patients undergoing CABG.
  • Logistic regression models were employed to assess the effect of cirrhosis on key outcomes.

Main Results:

  • Cirrhotic patients (0.2% of total) had a significantly increased risk of mortality (17% vs. 3%) and complications (43% vs. 28%) after CABG.
  • Cirrhosis was associated with longer hospital stays and higher charges (P<0.0001).
  • Predictors of mortality included age, female gender, ascites, and congestive heart failure; hospital volume and off-pump CABG did not impact mortality.

Conclusions:

  • Patients with cirrhosis experience a substantially elevated risk of morbidity and mortality post-CABG surgery.
  • Further research is needed to improve risk stratification for this high-risk group.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...